GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » 5-Year EBITDA Growth Rate

BioVaxys Technology (BioVaxys Technology) 5-Year EBITDA Growth Rate : 0.00% (As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology 5-Year EBITDA Growth Rate?

BioVaxys Technology's EBITDA per Share for the three months ended in Jul. 2023 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was -26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of BioVaxys Technology was -26.00% per year. The lowest was -26.00% per year. And the median was -26.00% per year.


Competitive Comparison of BioVaxys Technology's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, BioVaxys Technology's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioVaxys Technology's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's 5-Year EBITDA Growth Rate falls into.



BioVaxys Technology 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


BioVaxys Technology  (OTCPK:BVAXF) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


BioVaxys Technology 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.